Anumantha G. Kanthasamy,Ahmed Abdalla,Gregory Phillips,Nicholas Backes
申请号：
US16287437
公开号：
US20190262298A1
申请日:
2019.02.27
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention generally provides methods and compositions for the treatment of Parkinson's disease and depression and/or anxiety. The invention relates to recombinant microorganisms, particularly gut-colonizing probiotics, modified to produce L-DOPA.
